Article
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution.
Virus research - 15 Jun 2016
Magnus Carsten, Reh Lucia, Trkola Alexandra
Abstract excerpt
Broadly neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) are considered vital components of novel therapeutics and blueprints for vaccine research. Yet escape to even the most potent of these antibodies is imminent in natural infection. Measures to define antibody efficacy and prevent mutant selection are thus urgently needed. Here, we derive a mathematical framework to predict the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
